This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Finland, France, Hong Kong, Ireland, Japan, Malta, Netherlands, New Zealand, Tunisia, Turkey, United Kingdom
The drug BRICANYL contains one active pharmaceutical ingredient (API):
|
1
Terbutaline
UNII 576PU70Y8E - TERBUTALINE SULFATE
|
|
Terbutaline is a selective beta2-adrenoceptor agonist, thus producing relaxation of bronchial smooth muscle, inhibition of the release of endogenous spasmogens, inhibitions of oedema caused by endogenous mediators, increased mucociliary clearance and relaxation of the uterine muscle. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| BRICANYL Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| BRICANYL Solution for injection or infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| BRICANYL TURBOHALER Inhalation powder | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03AC03 | Terbutaline | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists |
| R03CC03 | Terbutaline | R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 1034K, 12267P, 2817G |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 502300801139315, 502300901133319 |
| Country: CA | Health Products and Food Branch | Identifier(s): 00786616 |
| Country: EE | Ravimiamet | Identifier(s): 1225145, 1628793, 1734724, 1751026, 1781906 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 068001, 379698 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60961427, 62600742, 68242177 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 138379, 26851, 26858, 28294, 299801, 36340, 365069, 375768, 377581, 393592 |
| Country: HK | Department of Health Drug Office | Identifier(s): 19618, 30992 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 15458, 37420, 76408 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2252003F1085, 2252003Q1035, 2252401A1030 |
| Country: MT | Medicines Authority | Identifier(s): AA227/00903 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 13777785, 15685586 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 152013, 152021 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 1302 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5100012, 5100016, 5100017H, 5100018, 5100019 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699786010406 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
